ID   CML1_RAT                Reviewed;         372 AA.
AC   O35786; G3V625;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   29-SEP-2021, sequence version 2.
DT   27-MAR-2024, entry version 136.
DE   RecName: Full=Chemerin-like receptor 1;
DE   AltName: Full=Chemokine-like receptor 1;
DE   AltName: Full=G-protein coupled chemoattractant-like receptor;
DE   AltName: Full=G-protein coupled receptor DEZ;
GN   Name=Cmklr1; Synonyms=Dez;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Albino; TISSUE=Pituitary anterior lobe;
RX   PubMed=9425281; DOI=10.1006/bbrc.1997.7822;
RA   Owman C.S.O., LoLait S.J., Santen S., Olde B.;
RT   "Molecular cloning and tissue distribution of cDNA encoding a novel
RT   chemoattractant-like receptor.";
RL   Biochem. Biophys. Res. Commun. 241:390-394(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-338; THR-341; SER-348 AND
RP   SER-357, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Receptor for the chemoattractant adipokine chemerin/RARRES2
CC       and for the omega-3 fatty acid derived molecule resolvin E1.
CC       Interaction with RARRES2 initiates activation of G proteins G(i)/G(o)
CC       and beta-arrestin pathways inducing cellular responses via second
CC       messenger pathways such as intracellular calcium mobilization,
CC       phosphorylation of MAP kinases MAPK1/MAPK3 (ERK1/2), TYRO3,
CC       MAPK14/P38MAPK and PI3K leading to multifunctional effects, like,
CC       reduction of immune responses, enhancing of adipogenesis and
CC       angionesis. Resolvin E1 down-regulates cytokine production in
CC       macrophages by reducing the activation of MAPK1/3 (ERK1/2) and NF-
CC       kappa-B. Positively regulates adipogenesis and adipocyte metabolism (By
CC       similarity). {ECO:0000250|UniProtKB:Q99788}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q99788};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: High expression in heart and lung, low in small
CC       intestines, colon, kidney, liver, uterus and brain.
CC       {ECO:0000269|PubMed:9425281}.
CC   -!- SIMILARITY: Belongs to the chemokine-like receptor (CMKLR) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ002745; CAA05715.1; -; mRNA.
DR   EMBL; AC128917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473973; EDM13970.1; -; Genomic_DNA.
DR   EMBL; CH473973; EDM13971.1; -; Genomic_DNA.
DR   PIR; JC5796; JC5796.
DR   RefSeq; NP_071554.2; NM_022218.2.
DR   RefSeq; XP_006249567.1; XM_006249505.3.
DR   RefSeq; XP_006249568.1; XM_006249506.3.
DR   RefSeq; XP_006249569.1; XM_006249507.3.
DR   RefSeq; XP_006249570.1; XM_006249508.3.
DR   RefSeq; XP_006249571.1; XM_006249509.3.
DR   AlphaFoldDB; O35786; -.
DR   SMR; O35786; -.
DR   STRING; 10116.ENSRNOP00000000893; -.
DR   GlyCosmos; O35786; 2 sites, No reported glycans.
DR   GlyGen; O35786; 2 sites.
DR   iPTMnet; O35786; -.
DR   PhosphoSitePlus; O35786; -.
DR   PaxDb; 10116-ENSRNOP00000000893; -.
DR   Ensembl; ENSRNOT00000000893.4; ENSRNOP00000000893.2; ENSRNOG00000000704.4.
DR   Ensembl; ENSRNOT00000097365.1; ENSRNOP00000089521.1; ENSRNOG00000000704.4.
DR   Ensembl; ENSRNOT00000101222.1; ENSRNOP00000085339.1; ENSRNOG00000000704.4.
DR   Ensembl; ENSRNOT00000105285.1; ENSRNOP00000091942.1; ENSRNOG00000000704.4.
DR   Ensembl; ENSRNOT00055003634; ENSRNOP00055002731; ENSRNOG00055002284.
DR   Ensembl; ENSRNOT00055003635; ENSRNOP00055002732; ENSRNOG00055002284.
DR   Ensembl; ENSRNOT00055003638; ENSRNOP00055002733; ENSRNOG00055002284.
DR   Ensembl; ENSRNOT00055003639; ENSRNOP00055002734; ENSRNOG00055002284.
DR   Ensembl; ENSRNOT00060012066; ENSRNOP00060009096; ENSRNOG00060007338.
DR   Ensembl; ENSRNOT00060012070; ENSRNOP00060009099; ENSRNOG00060007338.
DR   Ensembl; ENSRNOT00060012076; ENSRNOP00060009106; ENSRNOG00060007338.
DR   Ensembl; ENSRNOT00060012078; ENSRNOP00060009107; ENSRNOG00060007338.
DR   Ensembl; ENSRNOT00065011157; ENSRNOP00065008149; ENSRNOG00065007172.
DR   Ensembl; ENSRNOT00065011159; ENSRNOP00065008150; ENSRNOG00065007172.
DR   Ensembl; ENSRNOT00065011161; ENSRNOP00065008151; ENSRNOG00065007172.
DR   Ensembl; ENSRNOT00065011166; ENSRNOP00065008155; ENSRNOG00065007172.
DR   GeneID; 60669; -.
DR   KEGG; rno:60669; -.
DR   UCSC; RGD:69359; rat.
DR   AGR; RGD:69359; -.
DR   CTD; 1240; -.
DR   RGD; 69359; Cmklr1.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230438; -.
DR   HOGENOM; CLU_009579_8_0_1; -.
DR   InParanoid; O35786; -.
DR   OMA; IIMSCPS; -.
DR   OrthoDB; 5384006at2759; -.
DR   PhylomeDB; O35786; -.
DR   TreeFam; TF330976; -.
DR   Reactome; R-RNO-373076; Class A/1 (Rhodopsin-like receptors).
DR   PRO; PR:O35786; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Proteomes; UP000234681; Chromosome 12.
DR   Bgee; ENSRNOG00000000704; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0097004; F:adipokinetic hormone binding; ISS:UniProtKB.
DR   GO; GO:0097003; F:adipokinetic hormone receptor activity; ISS:UniProtKB.
DR   GO; GO:0004875; F:complement receptor activity; IBA:GO_Central.
DR   GO; GO:0001637; F:G protein-coupled chemoattractant receptor activity; TAS:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; ISS:UniProtKB.
DR   GO; GO:0002430; P:complement receptor mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; ISS:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; ISO:RGD.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; ISS:UniProtKB.
DR   CDD; cd15116; 7tmA_CMKLR1; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR002258; CML1.
DR   InterPro; IPR000826; Formyl_rcpt-rel.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24225:SF49; CHEMERIN-LIKE RECEPTOR 1; 1.
DR   PANTHER; PTHR24225; CHEMOTACTIC RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01126; DEZORPHANR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..372
FT                   /note="Chemerin-like receptor 1"
FT                   /id="PRO_0000069309"
FT   TOPO_DOM        1..39
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        40..62
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        63..73
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        74..95
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        96..112
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        113..133
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        134..152
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..174
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        175..223
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        224..244
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        245..260
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        261..281
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        282..299
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        300..319
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..372
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         341
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97468"
FT   MOD_RES         357
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         371
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97468"
FT   CARBOHYD        7
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        191
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        110..188
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        164..170
FT                   /note="LAFFLSS -> WLSSESP (in Ref. 1; CAA05715)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176..178
FT                   /note="RDT -> GH (in Ref. 1; CAA05715)"
FT   CONFLICT        251
FT                   /note="L -> Q (in Ref. 1; CAA05715)"
SQ   SEQUENCE   372 AA;  41865 MW;  478D475020E6BEDC CRC64;
     MEYEGYNDSS IYGEEYSDGS DYIVDLEEAG PLEAKVAEVF LVVIYSLVCF LGILGNGLVI
     VIATFKMKKT VNTVWFVNLA VADFLFNIFL PIHITYAAMD YHWVFGKAMC KISSFLLSHN
     MYTSVFLLTV ISFDRCISVL LPVWSQNHRS VRLAYMTCVV VWVLAFFLSS PSLVFRDTVS
     TSHGKITCFN NFSLAAPEPF SHSTHPRTDP VGYSRHVAVT VTRFLCGFLI PVFIITACYL
     TIVFKLQRNR LAKTKKPFKI IITIIITFFL CWCPYHTLYL LELHHTAVPA SVFSLGLPLA
     TAVAIANSCM NPILYVFMGH DFKKFKVALF SRLVNALSED TGPSSYPSHR SFTKMSSLIE
     KASVNEKETS TL
//
